The Cardioprotective Effect of Glucagon-Like Peptide 1 Receptor Agonist ina Trial Inspired, And Wider, Population Individuals Living with Type 2Diabetes: A Target Trial Emulation Study in CPRD
by Prateek Chopra | June 23, 2026 | Diabetes Conferences | ADA 2026 Clinical Context Methods Study Population Cardiovascular Outcomes in the Trial-Matched Cohort Cardiovascular Outcomes in the Non-Trial Cohort Clinical Implications GLP-1RA therapy was associated with a lower risk of major adverse cardiovascular events among individuals meeting LEADER trial eligibility criteria but not among those outside the trial population. […]